Table 2 Cardiovascular risk profile of study patients with and without MRI-detected silent ischemic lesions
Silent ischemic brain lesions | ||||
|---|---|---|---|---|
No (n = 161) | Yes (n = 14) | p-value* | ||
≥1 stroke risk factor** | No | 44 (27.3) | 4 (28.6) | > 0.999 |
Yes | 137 (72.7) | 10 (71.4) | ||
Age; median (IQR) | 60 (54–66) | 67 (61–69) | 0.026 | |
Female sex; n (%) | 50 (31.1) | 6 (42.9) | 0.318 | |
Congestive heart failure; n (%) | 11 (6.8) | 1 (7.1) | > 0.999 | |
Arterial hypertension; n (%) | 94 (58.4) | 6 (42.9) | 0.275 | |
Diabetes mellitus; n (%) | 15 (9.3) | 2 (14.5) | 0.630 | |
Vascular disease; n (%) | 34 (21.1) | 1 (7.1) | 0.307 | |
Hyperlipoproteinemia; n (%) | 77 (47.8) | 10 (71.4) | 0.103 | |
Paroxysmal AF; n (%) | 109 (67.7) | 9 (64.3) | 0.773 | |
Dilated left atrium; n (%) | 70 (45.8) | 5 (41.7) | > 0.999 | |
Left ventricular ejection fraction < 50%; n (%) | 11 (7.0) | 0 (0) | > 0.999 | |